Most commonly reported side effects
MDL 3094 In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation has 346 litigants as of August 2023, an increase of 235 active cases over the past month, which is an over 200% jump in a single month
Whilst these medications have demonstrated significant efficacy in glycaemic control and weight reduction, their potential role in addressing disordered eating patterns, including binge eating, has emerged as an area of clinical and research interest
Our own glutathione supplement, Performance Lab Immune, is free from artificial preservatives and synthetic additives
Certain risk factors can make you more prone to developing a B12 deficiency
Many private label factories focus only on production, leaving the client responsible for branding, packaging design, and market positioning